Skip to content

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$330.96M+174%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$92.53M+37.0%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
-$94.39M-28.9%
ALN
Alnylam PharmaceuticalsALNY
$205.99M+1,229%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$94.32M+12.9%

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+10.1%
Enterprise value$615.92M-18.1%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's net income?
Wave Life Sciences (WVE) reported net income of -$26.09M in Q1 2026.
How has Wave Life Sciences's net income changed year-over-year?
Wave Life Sciences's net income increased by 44.4% year-over-year, from -$46.88M to -$26.09M.
What is the long-term trend for Wave Life Sciences's net income?
Over 3 years (2021 to 2025), Wave Life Sciences's net income has grown at a 18.7% compound annual growth rate (CAGR), from -$122.25M to -$204.38M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.